AIRNECFLU

Welcome to the Brand page for “AIRNECFLU”, which is offered here for Antiviral drugs; antibiotics; antibiotics for animals; chemical reagent for medical purposes; chemical reagent for veterinary purposes; germicides for animals; germicides; biocides for medical purposes; germicide for human use; biocides for veterinary purposes; medicines for human purposes namely, for treatment of virus infection, neuropsychiatric disorders, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, hyperactivity, anxiety, bipolar disorder, and other central nervous system disorders; medicine for human purposes namely, for improving basic behavioral functioning, suicidal ideation and/or behavior, sensorimotor gating, pain threshold, memory and/or cognitive functioning and loss weight; sedatives; nervines for pharmaceutical or medical purposes, for treating attention deficit hyperactivity disorder (adhd), schizophrenia, pain, depression, bipolar disorder, eating disorder, addiction disorder, personality disorder, psychotic disorder, tic disorder, post-traumatic stress disorder, anxiety, social anxiety disorder, panic disorder, autism, asperger's disorder, obsessive-compulsive disorder (ocd), learning disorder, tourette's syndrome, mild cognitive disorder (mci), benign forgetfulness, closed head injury, dementia, vascular dementia, alzheimer's disorder, frontotemporal dementia, parkinson's disorder, huntington's disease, nocturnal enuresis, blepharospasm, non-epileptic seizure, premenstrual syndrome, and amyotrophic lateral sclerosis (als); gases for pharmaceutical or medical purposes, for treating attention deficit hyperactivity disorder (adhd), schizophrenia, pain, depression, bipolar disorder, eating disorder, addiction disorder, personality disorder, psychotic disorder, tic disorder, post-traumatic stress disorder, anxiety, social anxiety disorder, panic disorder, autism, asperger's disorder, obsessive-compulsive disorder (ocd), learning disorder, tourette's syndrome, mild cognitive disorder (mci), benign forgetfulness, closed head injury, dementia, vascular dementia, alzheimer's disorder, frontotemporal dementia, parkinson's disorder, huntington's disease, nocturnal enuresis, blepharospasm, non-epileptic seizure, premenstrual syndrome, and amyotrophic lateral sclerosis (als); medicinal spray namely, nasal spray for medical purposes, and oral spray for medical purposes;.

Its status is currently believed to be active. Its class is unavailable. “AIRNECFLU” is believed to be currently owned by “SyneuRx International (Taiwan) Corp.”